TEP1 / Telomerase protein component 1 · Western blot design guide

Design a Western Blot for TEP1

Source-linked TEP1 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-TEP1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.

Evidence assembled September 2026 · For research use; verify linked source records and product datasheet before use
Western blot protocol sheet for TEP1: expected band ~290.5 kDa, hero antibody A02017, catalog values and labelled standard workflow; separate PMC comparisons on the guide
Printable TEP1 Western blot protocol sheet — expected band ~290.5 kDa, antibody A02017, controls and PMC citations. Open the full TEP1 WB guide →

TEP1 Western Blot Experimental Design Guide

Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.

Must know before running
Expected band ~290.5 kDa
Gel 4–12% gradient (standard starting point)
Negative control ⓘ Suggested KO / knockdown lysate
Important caveats
Reasons your observed band may differ from the expected size.
PTM —
Caveat —
Gene-set association MSigDB C7 membership
Isoform 2 isoform(s)
Section 1

Source-Linked TEP1 Western Blot Protocol Options

The A02017 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.

Recommended Western blot protocol parameters
Sample / lysatehuman kidney tissue lysate (catalog A02017)
Gel %4–12% gradient (standard starting point)
Load20–30 µg total protein per lane; optimize for abundance (standard starting point)
TransferWet/tank transfer; optimize duration (standard starting point)
Membrane0.45 µm PVDF (standard starting point)
Blocking5% milk or 5% BSA in TBST (standard starting point)
Primary antibodyA02017 · (A) 0.5 and (B) 1 μg/mL (catalog A02017)
Primary incubationOvernight at 4 °C (standard starting point)
Secondary antibodySpecies-matched HRP conjugate at validated dilution (standard starting point)
Secondary incubation1 h at room temperature (standard starting point)
Wash3 × 5 min in TBST (standard starting point)
DetectionECL; bracket exposures to avoid saturation (standard starting point)
Section 2

What Is the Expected TEP1 Western Blot Band Size?

TEP1 is predicted at 290.5 kDa; alternative splicing may affect size, but no empirical migration or distinct isoform bands are demonstrated.

What am I looking at on my blot?
Band near 290.5 kDaConsistent with the predicted TEP1 mass; confirm identity with controls
Single band at another sizeMigration alone cannot establish TEP1 identity or an isoform assignment
Two bands at different sizesIsoforms 1 and 2 exist, but their migration difference is unknown
Band enriched in a nuclear fractionConsistent with TEP1's nuclear location; confirm identity with controls
💡Expected TEP1 appearanceTEP1 has a predicted mass of 290.5 kDa, but no empirical band size is supplied; use appropriate band-identity controls to assess any detected band.
How each factor affects band size
Predicted TEP1 massProvides a 290.5 kDa reference, not a measured migration position
Isoform 1Its separate mass and migration are not supplied
Isoform 2Its separate mass and migration are not supplied
Alternative splicingMay affect protein size, but distinct bands are not established
Why is my band missing or off?
SituationLikely causeNext action
No band in lysateNuclear TEP1 may be difficult to detect in whole-cell lysateCheck a nuclear fraction and a validated positive control
Band higher than expectedThe band cannot be assigned to TEP1 by size aloneCheck antibody specificity with a TEP1-depleted sample
Band lower than expectedAn isoform assignment cannot be made without isoform sizesCompare with a TEP1-depleted sample and an isoform-specific control if available
Multiple bandsAlternative splicing is documented, but distinct isoform bands are not establishedIdentify TEP1-dependent bands with a depletion control
Weak or no signalThe nuclear target may be diluted in whole-cell lysateEnrich the nuclear fraction and check a validated positive control

Sample controls for TEP1 Western blot

🧪For positive controls for TEP1 in Western blot, you can use no HPA-supported tissue or cell line because no positive candidates were supplied.
Positive control: No high/medium HPA tissue identified
Negative control: Suggested KO / knockdown lysate
Loading controls: Run GAPDH, β-actin, and a total-protein stain alongside the samples.
⚠️Feasibility: HPA data are unavailable, so tissue controls cannot be selected or validated from the supplied evidence.

HPA tissue expression evidence for TEP1

Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.

Higher expression tissues · candidate positive controls from IHC

TissueCell typeLevelEvidenceSource
No high/medium HPA tissues identified in the supplied evidence.

Lower expression tissues · IHC evidence, not confirmed WB-negative controls

TissueCell typeLevelEvidenceSource
No lower-expression tissue rows available in the supplied evidence.
Section 3

Advanced TEP1 Western Blot Tips

Deeper troubleshooting and optimisation questions for TEP1, answered from its protein features.

How should TEP1 band migration be interpreted?
Band shift · Use the separately labelled calculated mass and catalog-observed evidence above. A sequence annotation does not establish an observed migration shift. Verify target identity with orthogonal controls.
Can TEP1 isoforms produce different bands?
Isoforms · UniProt lists two isoforms. In isoform 2, a 32-residue segment at canonical positions 2475–2506 is replaced by a 25-residue segment. This sequence difference does not establish that the isoforms resolve as separate bands.

Examine the altered sequence at positions 2475–2506 in UniProt canonical numbering. An antibody against a sequence shared by both isoforms cannot distinguish them; an antibody targeting the isoform-specific sequence may. Check the antibody's stated numbering convention before comparing coordinates.
Do annotated modifications prove a band shift?
PTM · The linked UniProt record describes protein features. A modification annotation alone does not demonstrate a visible shift; retain any condition or experimental qualifier attached to it.
Does this guide establish induction of TEP1?
Induction · No general induction response is established by this guide. A pathway or gene-set association is not evidence of induction in a particular specimen. Verify the relevant treatment and control in a target-specific experiment.
What transfer method to use for TEP1 Western blot?
Transfer · TEP1 is predicted to be 290.5 kDa. Choose a transfer setup suitable for a protein of that size, then check transfer with a high-mass marker and a total-protein stain. The supplied features do not specify a membrane, transfer time, or voltage.
How should blocking be optimized?
Blocking · Standard workflow guidance: follow the A02017 datasheet where specified. Otherwise compare 5% milk or 5% BSA in TBST; for a phospho-specific assay start with BSA. Optimize background and specific signal with matched controls.
How should TEP1 be quantified?
Quantitation · Standard workflow guidance: quantify only a validated target band within the linear exposure range. Use consistent sample preparation and loading, retain biological replicates, and avoid interpreting saturation or loading differences as regulation.
Should TEP1 run at its predicted 290.5 kDa?
Interpretation · 290.5 kDa is the predicted mass; no observed band size is supplied. Use a high-mass marker to assess migration, and do not treat a difference from 290.5 kDa alone as evidence of a modification.

Keep sample preparation consistent and compare signals within the assay's linear range. State whether samples are whole-cell or enriched fractions: UniProt places TEP1 in the nucleus and at telomeres and lists it as a component of telomerase and vault particles.

Check the band against the predicted 290.5 kDa mass and the antibody's recognized sequence. The two annotated isoforms differ near the C-terminus, but their existence alone does not identify an unexpected band. No signal peptide, propeptide, modified residue, or glycosylation site is listed to support a specific processing or modification explanation.
Boster reagents

TEP1 Western Blot Antibodies

Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.

Real WB data Western blot analysis of TP1 in human kidney tissue lysate with TP1 antibody at (A) 0.5 and (B) 1 μg/mL.
Anti-TP1 TEP1 Antibody
Cat # A02017

the supplier A02017 is an anti-TEP1 antibody listed for human, mouse, and rat. Its Western blot image shows human kidney tissue lysate tested at 0.5 and 1 μg/mL; the supplied evidence does not show mouse or rat blots.

Which to pick: A02017 is the only listed option. Its Western blot image supports use in the reported human kidney lysate conditions; mouse and rat reactivity is listed but not shown in the supplied image.

Source: BosterBio TEP1 gene-info card — filtered to Western-blot-capable antibodies; each card shows that product's actual WB validation figure.

References

  1. UniProt Consortium. UniProt entry Q99973.
  2. Human Protein Atlas. TEP1 tissue expression.
  3. PMC12217205 — target-verified WB comparison